The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis
Published version of a preprint
Abstract
Purpose: Fusobacterium nucleatum (F. nucleatum) is a component of the human microbiome that primarily inhabits the oral cavity. It causes periodontal disease and has also been implicated in the development of human cancers. Although there are several reports of the relationship between F. nucleatum and the clinical outcome in human cancers, its prognostic significance in esophageal cancer remains unclear. Experimental Design: We quantified F. nucleatum DNA in 325 resected esophageal cancer specimens by qPCR. Significant pathways in F. nucleatum–positive esophageal cancer tissues were identified by Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis using microarray data. Results: Esophageal cancer tissues contained significantly more F. nucleatum DNA than matched normal esophageal mucosa (P = 0.021; n = 60). F. nucleatum DNA was detected in 74 of 325 cases (23%). F. nucleatum DNA positivity was significantly associated with tumor stage, but not with sex, age, performance status, tobacco use, alcohol use, histology, tumor location, or preoperative treatment. F. nucleatum DNA positivity was also significantly associated with cancer-specific survival [log-rank P = 0.0039; univariate HR = 2.01; 95% confidence interval (CI), 1.22–3.23; P = 0.0068; multivariate HR = 1.78; 95% CI, 1.06–2.94; P = 0.031]. The top-ranked KEGG pathway in F. nucleatum–positive tissues was “cytokine–cytokine receptor interaction.” A significant relationship between F. nucleatum and the chemokine CCL20 was validated by IHC. Conclusions: F. nucleatum in esophageal cancer tissues was associated with shorter survival, suggesting a potential role as a prognostic biomarker. F. nucleatum might also contribute to aggressive tumor behavior through activation of chemokines, such as CCL20. Clin Cancer Res; 22(22); 5574–81. ©2016 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fusobacterium spp. is important in the development and progression of gastrointestinal tumors1,19,34,35”
From RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach (2020) · cites this paper as [34]
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,613
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., Mariat, D., Corthier, G., Doré, J., Henegar, C., et al. (2010) · Diabetes · doi:10.2337/db10-0253 · Cited by 1,173
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080
Self-citationGriffen, A. L., Beall, C. J., Campbell, J. H., Firestone, N. D., Kumar, P., Yang, Z. K., Podar, M., & Leys, E. J. (2011) · The ISME Journal · doi:10.1038/ismej.2011.191 · Cited by 1,006
Fusobacterium nucleatum: a commensal-turned pathogen
Han, Y. W. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.11.013 · Cited by 869
Cani, P. D., Osto, M., Geurts, L., & Everard, A. (2012) · Gut Microbes · doi:10.4161/gmic.19625 · Cited by 864
7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
Rice, T. W., Blackstone, E. H., & Rusch, V. W. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1024-1 · Cited by 797
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669
Self-citationCCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B. P., Martín‐Orozco, N., Kang, H. S., Ma, L., Panopoulos, A. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8391 · Cited by 567
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2081-3 · Cited by 498
Mitsuhashi, K., Nosho, K., Sukawa, Y., Matsunaga, Y., Ito, M., Kurihara, H., Kanno, S., Igarashi, H., Naito, T., Adachi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3109 · Cited by 404
Arthur, J. C., Gharaibeh, R. Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J. M., McCafferty, J., Fodor, A. A., & Jobin, C. (2014) · Nature Communications · doi:10.1038/ncomms5724 · Cited by 392
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 328
Yoneda, M., Naka, S., Nakano, K., Wada, K., Endo, H., Mawatari, H., Imajo, K., Nomura, R., Hokamura, K., Ono, M., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-16 · Cited by 307
Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., & Sato, N. (2002) · Gut · doi:10.1136/gut.52.1.79 · Cited by 300
Ito, M., Kanno, S., Nosho, K., Sukawa, Y., Mitsuhashi, K., Kurihara, H., Igarashi, H., Takahashi, T., Tachibana, M., Takahashi, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29488 · Cited by 288
Identification and Characterization of a Novel Adhesin Unique to Oral Fusobacteria
Han, Y. W., Ikegami, A., Rajanna, C., Kawsar, H. I., Zhou, Y., Li, M., Sojar, H. T., Genco, R. J., Kuramitsu, H. K., & Deng, C. X. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5330-5340.2005 · Cited by 260
Chen, K., Lin, S., Zhou, L., Xie, H., Zhou, W., Taki‐Eldin, A., & Zheng, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024671 · Cited by 247
Verbeke, H., Karel, G., Damme, J. V., & Struyf, S. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.008 · Cited by 157
Chemoradiation in the Management of Esophageal Cancer
Kleinberg, L. R., & Forastiere, A. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0881 · Cited by 157
Furusho, H., Miyauchi, M., Hyogo, H., Inubushi, T., Ao, M., Ouhara, K., Hisatune, J., Kurihara, H., Sugai, M., Hayes, C. N., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0738-1 · Cited by 157
Centralization of Esophageal Cancer Surgery: Does It Improve Clinical Outcome?
Wouters, M. W. J. M., Karim-Kos, H. E., le Cessie, S., Wijnhoven, B. P. L., Stassen, L. P. S., Steup, W. H., Tilanus, H. W., & Tollenaar, R. A. �. �. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0458-9 · Cited by 156
Cook, K., Letley, D. P., Ingram, R. J. M., Staples, E., Skjoldmose, H., Atherton, J. C., & Robinson, K. (2014) · Gut · doi:10.1136/gutjnl-2013-306253 · Cited by 153
Liu, J. Y., Li, F., Wang, L. P., Chen, X., Wang, D., Cao, L., Yü, P., Zhao, S., Li, B., Thorne, S. H., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.290 · Cited by 119
Wang, B., Shi, L., Sun, X., Wang, L., Wang, X., & Chen, C. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12781 · Cited by 97
Tobacco smoke induces production of chemokine CCL20 to promote lung cancer
Wang, G., Cheng, X., Li, X., Liu, Y., Wang, X.-Q., Shi, X., Wang, Z.-Y., Guo, Y., Wen, Z., Huang, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.005 · Cited by 92
Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma
Ogura, M., Takeuchi, H., Kawakubo, H., Nishi, T., Fukuda, K., Nakamura, R., Takahashi, T., Wada, N., Saikawa, Y., Omori, T., et al. (2013) · Surgery · doi:10.1016/j.surg.2013.06.013 · Cited by 76
Macrophage inflammatory protein-3α promotes pancreatic cancer cell invasion
Campbell, A. S., Albo, D., Kimsey, T. F., White, S. L., & Wang, T. N. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.07.013 · Cited by 71
Tahara, T., Shibata, T., Kawamura, T., Okubo, M., Ichikawa, Y., Sumi, K., Miyata, M., Ishizuka, T., Nakamura, M., Nagasaka, M., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3316-y · Cited by 68
CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis
Nandi, B., Pai, C., Huang, Q. M., PRABHALA, R. H., Munshi, N. C., & Gold, J. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097566 · Cited by 52
Vicinus, B., Rubie, C., STEGMAIER, N., Frick, V. O., Kölsch, K., Kauffels, A., Ghadjar, P., Wagner, M., & Glanemann, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2580 · Cited by 40
CXCR7 expression in esophageal cancer
Tachezy, M., Zander, H., Gebauer, F., von Loga, K., Pantel, K., Izbicki, J. R., & Bockhorn, M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-238 · Cited by 35
Response to Preoperative Therapy in Upper Gastrointestinal Cancers
Brücher, B. L. D. M., Swisher, S. G., Königsrainer, A., Zieker, D., Hartmann, J. T., Stein, H. J., Kitagawa, Y., Law, S. Y.-K., & Ajani, J. A. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0315-x · Cited by 32
Łukaszewicz‐Zając, M., Mroczko, B., Kozłowski, M., & Szmitkowski, M. (2016) · Disease Markers · doi:10.1155/2016/7963895 · Cited by 31
Suzuki, H., Onishi, H., Morisaki, T., Tanaka, M., & Katano, M. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.10.007 · Cited by 27
Kretschmer, I., Freudenberger, T., Twarock, S., Yamaguchi, Y., Grandoch, M., & Fischer, J. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708909 · Cited by 17
Cited by
Sorted by citations
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989
RetractedParhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16967-2 · Cited by 716
(2023) · doi:10.1038/s41392-022-01304-4 · Cited by 460
The role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384
Metadata
- Authors
- Yamamura, K., Baba, Y., Nakagawa, S., Mima, K., Miyake, K., Nakamura, K., Sawayama, H., Kinoshita, K., Ishimoto, T., Iwatsuki, M., Sakamoto, Y., Yamashita, Y., Yoshida, N., Watanabe, M., & Baba, H.
- Affiliations
- Kumamoto University (JP)
- 1Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- The Cancer Institute Hospital (JP)
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2016-11-14
- Volume
- 22
- Issue
- 22
- Pages
- 5574-5581
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2537571631
- Cited by
- 457
- References
- 50
- Citations by year
- 2026: 33 · 2025: 68 · 2024: 70 · 2023: 60 · 2022: 51 · 2021: 69 · 2020: 54 · 2019: 24 · 2018: 11 · 2017: 16
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Fusobacterium nucleatum, esophageal cancer, gut microbiota, prognostic factors, cancer-specific survival, tumor stage, CCL20, cytokine-cytokine receptor interaction, chemokines, tumor microenvironment, periodontal disease
- MeSH terms
- Aged, DNA, Bacterial, Esophageal Neoplasms, Female, Humans, Male, Prognosis, Fusobacterium nucleatum, Chemokines, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
